Overview A Study in Sepsis Patients With Renal Failure Status: Terminated Trial end date: 2009-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the safety and tolerability of AP in sepsis patients with renal failure and to investigate the effect of AP on inflammatory and clinical parameters in sepsis patients with renal failure. Phase: Phase 2 Details Lead Sponsor: AM-Pharma